Watch for Falling Fees
Bargains aplenty in mutual fund world.
Bargains aplenty in mutual fund world.
Most types of mutual funds haven't changed their fees much in recent years. The one exception: index funds. Investors have benefited from the intense competition among exchange-traded funds. That has led traditional open-end index funds to cut their fees, too, and some brokers have dropped commissions for buying and selling ETFs.
Now, more fee cuts are on the way in both actively managed and index funds.
A Cheer and a Salute for the Admirals
Vanguard has announced de facto cuts by lowering the initial minimum investment for its Admiral share class of index funds to $10,000 from $100,000. In addition, actively managed Admiral shares have had their minimums cut from $100,000 to $50,000. The move means that the 1.8 million investors will save on fees.
The reductions apply to both stock and bond funds. For example, the expense ratio for Vanguard Total Stock Market Index drops from 0.18% for the Investor class (symbol (VTSMX)) to 0.07% for the Admiral class ( (VTSAX)). For Vanguard European Stock Index, the fee drops from 0.27% for the Investor class ( (VEURX)) to 0.16% for the Admiral class ( (VEUSX)).
Vanguard is making things easy for its clients by switching them to the cheaper class automatically. Check your account online or call customer service. If your money hasn't yet been moved to the Admiral funds, ask Vanguard to take action right away. The exchanges will be tax-free.
Free Mutual Funds
For the most amazing cuts of all, I call your attention to two Bridgeway funds. One is charging investors nothing. In the other case, Bridgeway is paying shareholders to invest. I kid you not.
The explanation: Bridgeway ties management fees to performance. Its funds tack on extra fees when they perform well and trim fees when they perform poorly. Results have been awful the past three years, so the sponsor is paying the price. As a result, the current expense ratio for Bridgeway Aggressive Investors 1 (BRAGX) is a remarkable negative 0.51%. (In theory, this means that if the fund grossed 10% over the coming year and the sponsor continued to reimburse the fund at the current rate, investors would earn 10.51%.) The fund is shut to new customers. But if you already own it, hold on. (I'd hold on to just about any fund whose sponsor was paying me to invest.)
Then there's Bridgeway Micro-Cap Limited Fund , which has a 0% expense ratio and is open to new investors. Performance has been lousy over the past five years, but the fund has outpaced its peer group (small-company growth funds) by a wide margin since its 1998 inception. Funds that invest in tiny companies, as Bridgeway does, typically charge more than 1.5% a year, so getting Micro-Cap at no charge is a bargain. I wouldn't use the Bridgeway funds for the core of my investment program, but I could see using them to juice up my portfolio around the edges.
Who Else?
Other fee cuts are on the way. Putnam is cutting fees on its absolute return funds. Performance has been tepid so far so I won't be rushing in.
In addition, the merger of Columbia and RiverSource is going to lead to lower fees at a number of funds. Stay tuned for details.
Finally, I'll get a little speculative and throw out an idea rather than a certain fee cut. It's possible PIMCO will have a fee cut for investors in its A and D shares. Allianz is responsible for selling PIMCO's funds to the masses and, like many insurers, tries to get as much as it can. So, it charges 0.90% a year, for example, for PIMCO Total Return A (PTTAX) and 0.75% a year for PIMCO Total Return D , even though the fund's assets (in all classes combined) have grown to more than $250 billion. It's a similar story at other PIMCO funds.
But PIMCO is reclaiming responsibility for distributing its funds to retail investors, and there are hints of coming fee reductions. I don't know whether that means fees will drop by two-hundredths of a percentage point or by 20-hundredths. But given today's meager bond yields, reductions of any size would help. Let's hope they're bigger rather than smaller.
This article originally appeared in Kiplinger's.
FundInvestor Newsletter | ||||
Morningstar FundInvestor is a 48-page newsletter dedicated to helping investors pick great mutual funds, build winning portfolios, and monitor their funds for greater | gains. This one-year subscription consists of 12 monthly issues, a Reader's Guide, and four free investing reports. Learn more. | |||
$115.00 for 12 Print Issues | $95.00 for 12 PDF Issues | |||
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.